Trastuzumab Administered Concurrently or Sequentially to Anthracycline-containing Adjuvant Regimen for Breast Cancer
Clinical trial NCT01413828 · COMPLETED
Trial details
- NCT number
- NCT01413828
- Sponsor
- Peking Union Medical College Hospital
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2016-08-01
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.